⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MIRA News
MIRA Pharmaceuticals, Inc. Common Stock
MIRA Pharmaceuticals Announces Favorable Topline Results from Phase 1 SAD Study of Oral Ketamir-2, a Next-Generation Non-Scheduled Ketamine Analog
accessnewswire.com
MIRA
MIRA
MIRA Pharmaceuticals Reports Positive PTSD Data Demonstrating Ketamir-2 Restores Normalized Behavior in Stressed Animals
accessnewswire.com
MIRA
MIRA Pharmaceuticals Shareholders Approve Acquisition of SKNY Pharmaceuticals, Advancing Next-Generation Oral Therapeutic for Obesity and Smoking Cessation
accessnewswire.com
MIRA